For current clinical use, semaglutide has no peer in terms of evidence quality, regulatory status, and real-world experience
common: mild nausea (10%), injection site redness
2022 for retatrutide, Carmona et al
GLP-1 weight loss medications help regulate your appetite and insulin response, but they dont shut down your bodys natural systems
I know change is very difficult for people with autism (my son has autism too) but it sounds like it would hurt less and be easier for you to confidently treat her if you change injection site
Although they are a diverse group, DPP4i are all small, orally available molecules that interact with the catalytic site of DPP4 without disturbing any of its other known functions, including its effects on the immune system